Beth Hoffman - Y Combinator Founder of Origami Therapeutics, Inc.
Home›Founders›Beth Hoffman
Beth Hoffman, Founder of Origami Therapeutics, Inc.

Founder at Origami Therapeutics, Inc.

At Origami Therapeutics, Dr. Hoffman is creating a new approach to drug discovery for neurodegenerative diseases. Prior to Origami, she was a Research & Development executive at Vertex Pharmaceuticals, Amgen and Eli Lilly. She has made major contributions to >30 clinical programs in neurology, pain and psychiatry and to four marketed drugs for Cystic Fibrosis. Dr. Hoffman received her A.B. in Molecular Biology from Wellesley College and a Ph.D. in Cell Biology from the Johns Hopkins University.

Previously at

Vertex Pharmaceuticals
Vertex Pharmaceuticals
Amgen
Amgen
Eli Lilly & Company
Eli Lilly & Company
Alumnus of
Wellesley College
Wellesley College
Johns Hopkins University
Johns Hopkins University